5-Amino-1MQ Research Update 2026
A comprehensive synthesis of 2024–2026 preclinical publications evaluating 5-Amino-1MQ in cellular and animal models. As a small-molecule, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), this research compound continues to serve as a vital tool in metabolic and epigenetic laboratory investigations.
Quick answer
A comprehensive synthesis of 2024–2026 preclinical publications evaluating 5-Amino-1MQ in cellular and animal models. As a small-molecule, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), this research compound continues to serve as a vital tool in metabolic and epigenetic laboratory investigations.
Key takeaways
- In contemporary bio-energetic research, [5-Amino-1MQ](/research-peptides/5-amino-1mq) (5-amino-1-methylquinoliniiium) represents one of the most selective membrane-permeable small-molecule inhibitors of nicotinamide N-methyltransferase (NNMT).
- The metabolic relationship between NNMT expression and intracellular [NAD+](/research-peptides/nad-plus) availability is a focal point of current cellular bioenergetics.
- Literature published between 2024 and 2026 has expanded the scope of [5-Amino-1MQ](/research-peptides/5-amino-1mq) beyond baseline enzyme kinetic assays.
- Mitochondrial dysfunction often correlates with reduced mitochondrial density and suppressed oxygen consumption rates (OCR).
Overview of 5-Amino-1MQ and NNMT Inhibitory Dynamics
In contemporary bio-energetic research, 5-Amino-1MQ (5-amino-1-methylquinoliniiium) represents one of the most selective membrane-permeable small-molecule inhibitors of nicotinamide N-methyltransferase (NNMT). Nicotinamide N-methyltransferase is a cytosolic enzyme responsible for methylating nicotinamide (NAM) using S-adenosylmethionine (SAM) as the primary methyl donor, producing N1-methylnicotinamide (MNAM) and S-adenosylhomocysteine (SAH). Elevated NNMT activity deplete cellular pools of free nicotinamide and SAM, which restricts the salvage pathway necessary for nicotinamide adenine dinucleotide (NAD+) synthesis while simultaneously altering histone methylation patterns.
Recent 5-amino-1mq 2026 preclinical publications emphasize the compound's capacity to cross cell membranes efficiently without requiring complex delivery vectors. By competitive binding at the catalytic site of NNMT, 5-Amino-1MQ blocks the conversion of NAM to MNAM. Researchers utilizing this probe in laboratory protocols monitor the downstream restoration of intrasomatic NAD+ levels, making it a critical reagent for dissecting energy homeostatic networks in vitro and in rodent model systems.
The NNMT-NAD+ Axis in Cellular Bioenergetics
The metabolic relationship between NNMT expression and intracellular NAD+ availability is a focal point of current cellular bioenergetics. Under conditions where NNMT expression is upregulated—such as in high-fat diet rodent models or senescence-associated cell culture lines—nicotinamide salvage is constrained. Because NAD+ serves as an essential coenzyme for mitochondrial electron transport chain complexes, sirtuins (SIRT1-7), and poly(ADP-ribose) polymerases (PARPs), its depletion compromises cellular oxidative capacity.
Preclinical investigations demonstrate that application of 5-Amino-1MQ prevents the catalytic clearance of nicotinamide. This enzymatic blockade rescues the salvage pathway, allowing nicotinamide phosphoribosyltransferase (NAMPT) to efficiently convert NAM back into nicotinamide mononucleotide (NMN), which subsequently phosphorylates to yield functional NAD+. Laboratory assessments using nuclear magnetic resonance (NMR) spectroscopy and liquid chromatography-mass spectrometry (LC-MS) confirm significant shifts in the NAD+/NADH ratio following target inhibition in isolated adipose and skeletal muscle tissue preparations.
2024–2026 Preclinical Literature Review: Key Findings
Literature published between 2024 and 2026 has expanded the scope of 5-Amino-1MQ beyond baseline enzyme kinetic assays. Recent rodent studies demonstrate that systematic administration of selective NNMT inhibitors in Murine models subjected to metabolic stress leads to enhanced energy expenditure independently of food intake alteration. Researchers observed marked reductions in white adipose tissue (WAT) adipocyte hypertrophy alongside upregulation of uncoupling protein 1 (UCP1) transcripts in brown and beige adipose depots.
In vitro data published in 2025 further explored epigenomic signaling cross-talk. Because SAM serves as a universal donor for DNA and histone methyltransferases, blocking NNMT mediated SAM consumption maintains methyl donor availability for H3K4 and H3K27 methylation events. Consequently, researchers documented distinct epigenetic remodeling events in cultured cell lines, shedding light on how NNMT regulates both metabolic throughput and gene transcription cascades. For detailed analyses of related molecular probes, researchers can consult the PX1 research library.
Mitochondrial Respiration and ATP Production Insights
Mitochondrial dysfunction often correlates with reduced mitochondrial density and suppressed oxygen consumption rates (OCR). Investigators assessing 5-Amino-1MQ in microplate oxygen flux assays (such as Seahorse XF analysis) report significant improvements in basal, maximal, and ATP-linked respiration in primary adipocyte and myoblast cultures exposed to the inhibitor.
This elevated respiration is tied directly to SIRT1 activation downstream of augmented NAD+ pools. Activated SIRT1 deacetylates peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a master regulator of mitochondrial biogenesis. Preclinical data confirm increased mitochondrial DNA (mtDNA) copy numbers and higher protein expression of electron transport chain Complexes I, III, and IV following continuous 5-Amino-1MQ exposure in vitro.
Lipid Metabolism and Adipocyte Differentiation Models
Research focused on adipose tissue biology frequently investigates how NNMT modulates lipogenesis and lipolysis. Cultured 3T3-L1 adipocytes treated with 5-Amino-1MQ display attenuated lipid droplet accumulation during differentiation phases. Mechanistic assays indicate that NNMT suppression downregulates key lipogenic transcription factors, including sterol regulatory element-binding protein 1c (SREBP-1c) and fatty acid synthase (FAS).
Simultaneously, rodent research models demonstrate enhanced rate of fatty acid oxidation (FAO). By elevating intracellular NAD+ and stimulating AMP-activated protein kinase (AMPK) signaling, 5-Amino-1MQ shifts cellular substrate utilization toward beta-oxidation. These findings make 5-Amino-1MQ an invaluable benchmark compound when exploring novel targets within metabolic research compounds.
Comparative Analysis: 5-Amino-1MQ vs. Parallel Metabolic Modulators
When designing comparative bio-energetic study protocols, investigators frequently compare 5-Amino-1MQ against other small molecules and peptides targeted at mitochondrial or metabolic pathways. While MOTS-c operates as a mitochondrial-derived peptide regulating nuclear gene expression and glucose homeostasis, and AICAR acts as a direct nucleoside analog activator of AMPK, 5-Amino-1MQ uniquely targets the upstream enzymatic clearance of nicotinamide via direct NNMT inhibition. Additionally, comparative preclinical models evaluating multi-receptor agonists like Retatrutide research highlight distinct pathways: incretin receptor co-agonism drives systemic signaling, whereas 5-Amino-1MQ exerts direct cell-intrinsic control over methyl donor and NAD+ metabolic flux.
Unlike direct NAD+ research compounds that supply substrate exogenous precursors, 5-Amino-1MQ prevents the enzymatic degradation of endogenous nicotinamide. This distinction allows researchers to evaluate whether metabolic recovery is driven by exogenously added salvage pathway substrates or by preserving endogenous intracellular precursor pools.
In Vitro Assay Design and Research Reconstitution Protocol Guidelines
For laboratory experimental design, 5-Amino-1MQ is routinely evaluated across concentration gradients ranging from 1 µM to 100 µM in cell culture media, depending on the specific cell line and incubation duration. Enzymatic inhibition assays typically utilize purified recombinant human or rodent NNMT protein to determine IC50 values, which generally range between 1.2 µM and 2.5 µM in cell-free systems.
Reconstitution protocols require appropriate solvent selection based on assay conditions. 5-Amino-1MQ iodide or salt forms exhibit high solubility in dimethyl sulfoxide (DMSO) up to 20 mg/mL, and moderate solubility in sterile aqueous buffers such as Phosphate-Buffered Saline (PBS) at room temperature. Stock solutions prepared in DMSO should be aliquoted under sterile conditions and stored at -80°C to minimize freeze-thaw degradation. All handling must be conducted by qualified personnel using appropriate personal protective equipment strictly within laboratory environments.
Analytical Quality Control and Sourcing Standards for Laboratory Reagents
Data integrity in 2026 preclinical metabolic research depends entirely on the analytical purity and consistency of reference compounds. Impurities, residual synthesis solvents, or heavy metal contamination can disrupt sensitive cell culture assays, skew enzymatic kinetic constants, or induce non-specific cytotoxicity.
PX1 Research enforces rigorous multi-stage testing protocols for every synthesized batch. Each lot undergoes High-Performance Liquid Chromatography (HPLC) paired with Mass Spectrometry (MS) to confirm exact molecular mass and guarantee chemical purity exceeding 98%. Furthermore, reagents undergo chromogenic LAL assays for endotoxin quantification inside ISO 17025 accredited laboratories. Reagents are synthesized in USA-based, GMP-compliant facilities and shipped directly from California and Arizona facilities with same-day dispatch for orders finalized Monday through Friday before cut-off times. Institutional buyers interested in bulk quantities or dedicated lab supply lines can establish accounts via our wholesale portal.
Frequently Asked Questions
What is the primary mechanism of action of 5-Amino-1MQ in preclinical research?
5-Amino-1MQ functions as a membrane-permeable, selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking NNMT, it prevents the methylation of nicotinamide into N1-methylnicotinamide, preserving intracellular nicotinamide and S-adenosylmethionine (SAM) pools to support NAD+ synthesis.
How does 5-Amino-1MQ impact intracellular NAD+ levels in cell culture?
In vitro studies indicate that by inhibiting NNMT catalytic activity, 5-Amino-1MQ prevents the clearance of nicotinamide. This allows the salvage enzyme NAMPT to recycle nicotinamide into NMN and subsequently NAD+, raising intracellular NAD+ levels and enhancing SIRT1 activity.
What solvent is recommended for reconstituting 5-Amino-1MQ for in vitro assays?
5-Amino-1MQ dissolves readily in dimethyl sulfoxide (DMSO) at concentrations up to 20 mg/mL. It can also be diluted into sterile aqueous buffers such as PBS for working concentrations, provided stock solutions are prepared using proper sterile technique.
What analytical verifications are provided with PX1 Research 5-Amino-1MQ?
Every lot of 5-Amino-1MQ supplied by PX1 Research includes a lot-specific Certificate of Analysis (COA). Purity is verified via HPLC and MS to exceed 98%, and reagents undergo endotoxin testing in ISO 17025 accredited testing facilities.
How should 5-Amino-1MQ stock solutions be stored in the laboratory?
Lyophilized powder or solid standard should be stored at -20°C in a desiccated environment. Once reconstituted in DMSO, stock aliquots should be sealed, protected from light, and stored at -80°C to prevent degradation over multiple freeze-thaw cycles.
Is 5-Amino-1MQ intended for human clinical administration?
No. 5-Amino-1MQ is strictly a research compound manufactured exclusively for laboratory in vitro and animal research protocols. It is not approved for human or veterinary medical use, diagnostic procedures, or therapeutic administration.
Where are PX1 Research compounds synthesized and dispatched from?
PX1 Research compounds are USA-synthesized in GMP-compliant facilities. Orders are fulfilled directly from dispatch hubs in California and Arizona, with same-day shipping available for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.